dr. brufsky on trastuzumab biosimilars in breast cancer
Published 4 years ago • 127 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
0:51
dr. jhaveri on the use of trastuzumab biosimilars in breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:49
dr. brufsky discusses pertuzumab in her2 breast cancer
-
1:12
dr. esteva on trastuzumab biosimilar in breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
3:38
biosimilar trastuzumab
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:00
dr. slamon on the use of trastuzumab and bevacizumab biosimilars in breast cancer
-
1:49
dr. esteva on trastuzumab biosimilar in patients with her2 breast cancer
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
1:55
dr. kolberg on collecting real-world biosimilar trastuzumab data in breast cancer
-
0:54
dr. shah on the trastuzumab biosimilar in gastric cancer